Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NAGLU Antikörper (AA 24-489)

Dieses Anti-NAGLU-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von NAGLU in WB und ELISA. Geeignet für Human, Maus und Ratte.
Produktnummer ABIN7600838

Kurzübersicht für NAGLU Antikörper (AA 24-489) (ABIN7600838)

Target

Alle NAGLU Antikörper anzeigen
NAGLU (N-Acetylglucosaminidase, alpha (NAGLU))

Reaktivität

  • 12
  • 8
  • 5
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 19
  • 5
Kaninchen

Klonalität

  • 20
  • 4
Polyklonal

Konjugat

  • 20
  • 2
  • 2
Dieser NAGLU Antikörper ist unkonjugiert

Applikation

  • 23
  • 12
  • 10
  • 9
  • 5
  • 1
  • 1
Western Blotting (WB), ELISA
  • Bindungsspezifität

    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 24-489

    Verwendungszweck

    Anti-NAGLU Antibody Picoband®

    Kreuzreaktivität (Details)

    No cross-reactivity with other proteins

    Produktmerkmale

    Anti-NAGLU Antibody Picoband® (ABIN7600838). Tested in WB, ELISA applications. This antibody reacts with Human, Mouse, Rat. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.

    Aufreinigung

    Immunogen affinity purified.

    Immunogen

    E.coli-derived human NAGLU recombinant protein (Position: D24-D489).

    Isotyp

    IgG
  • Applikationshinweise

    Western blot, 0.25-0.5 μg/mL, Human, Mouse, Rat
    ELISA, 0.1-0.5 μg/mL
    1. Beesley, C. E., Young, E. P., Vellodi, A., Winchester, B. G. Identification of 12 novel mutations in the alpha-N-acetylglucosaminidase gene in 14 patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB). J. Med. Genet. 35: 910-914, 1998. 2. Bunge, S., Knigge, A., Steglich, C., Kleijer, W. J., van Diggelen, O. P., Beck, M., Gal, A. Mucopolysaccharidosis type IIIB (Sanfilippo B): identification of 18 novel alpha-N-acetylglucosaminidase gene mutations. J. Med. Genet. 36: 28-31, 1999. 3. Chinen, Y., Tohma, T., Izumikawa, Y., Uehara, H., Ohta, T. Sanfilippo type B syndrome: five patients with an R565P homozygous mutation in the alpha-N-acetylglucosaminidase gene from the Okinawa islands in Japan. J. Hum. Genet. 50: 357-359, 2005.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.

    Konzentration

    500 μg/mL

    Buffer

    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
  • Target

    NAGLU (N-Acetylglucosaminidase, alpha (NAGLU))

    Andere Bezeichnung

    NAGLU

    Hintergrund

    Synonyms: NAGLU, UFHSD1, Alpha-N-acetylglucosaminidase, EC 3.2.1.50, N-acetyl-alpha-glucosaminidase, NAG [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form, Alpha-N-acetylglucosaminidase 77 kDa form]

    Background: N-acetylglucosaminidase, alpha is a protein that in humans is encoded by the NAGLU gene. This gene encodes an enzyme that degrades heparan sulfate by hydrolysis of terminal N-acetyl-D-glucosamine residues in N-acetyl-alpha-D-glucosaminides. Defects in this gene are the cause of mucopolysaccharidosis type IIIB (MPS-IIIB), also known as Sanfilippo syndrome B. This disease is characterized by the lysosomal accumulation and urinary excretion of heparan sulfate.

    Molekulargewicht

    82 kDa

    Gen-ID

    4669

    UniProt

    P54802

    Pathways

    Glycosaminoglycan Metabolic Process
Sie sind hier:
Chat with us!